1. Home
  2. V vs LLY Comparison

V vs LLY Comparison

Compare V & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • V
  • LLY
  • Stock Information
  • Founded
  • V 1958
  • LLY 1876
  • Country
  • V United States
  • LLY United States
  • Employees
  • V N/A
  • LLY N/A
  • Industry
  • V Business Services
  • LLY Biotechnology: Pharmaceutical Preparations
  • Sector
  • V Consumer Discretionary
  • LLY Health Care
  • Exchange
  • V Nasdaq
  • LLY Nasdaq
  • Market Cap
  • V 651.3B
  • LLY 716.8B
  • IPO Year
  • V 2008
  • LLY N/A
  • Fundamental
  • Price
  • V $336.34
  • LLY $938.50
  • Analyst Decision
  • V Strong Buy
  • LLY Strong Buy
  • Analyst Count
  • V 25
  • LLY 15
  • Target Price
  • V $393.71
  • LLY $976.27
  • AVG Volume (30 Days)
  • V 5.6M
  • LLY 3.6M
  • Earning Date
  • V 10-28-2025
  • LLY 10-30-2025
  • Dividend Yield
  • V 0.80%
  • LLY 0.64%
  • EPS Growth
  • V 20.27
  • LLY 121.02
  • EPS
  • V 11.70
  • LLY 20.44
  • Revenue
  • V $40,000,000,000.00
  • LLY $59,419,800,000.00
  • Revenue This Year
  • V $13.34
  • LLY $40.23
  • Revenue Next Year
  • V $10.12
  • LLY $18.67
  • P/E Ratio
  • V $28.79
  • LLY $45.86
  • Revenue Growth
  • V 11.34
  • LLY 45.41
  • 52 Week Low
  • V $299.00
  • LLY $623.78
  • 52 Week High
  • V $375.51
  • LLY $955.46
  • Technical
  • Relative Strength Index (RSI)
  • V 41.35
  • LLY 79.30
  • Support Level
  • V $334.25
  • LLY $809.63
  • Resistance Level
  • V $342.11
  • LLY $955.46
  • Average True Range (ATR)
  • V 5.61
  • LLY 25.68
  • MACD
  • V -0.92
  • LLY 10.16
  • Stochastic Oscillator
  • V 15.23
  • LLY 89.51

About V Visa Inc.

Visa is the largest payment processor in the world. In fiscal 2024, it processed almost $16 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.

About LLY Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Share on Social Networks: